{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T09:37:37Z","timestamp":1765532257055,"version":"3.48.0"},"reference-count":20,"publisher":"Mattioli1885","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Introduction: Cutaneous malignant melanoma is a neoplastic transformation of melanocytes and a major cause of skin cancer\u2013related mortality. Ireland, with its fair-skinned population, continues to see rising incidence rates, highlighting the importance of identifying clinicopathological predictors of recurrence. Objectives: To assess the relationship between excision margins and melanoma recurrence, with emphasis on anatomical distribution and clinicopathological features. Methods: This retrospective observational study analyzed 565 patient records from University Hospital Waterford, Ireland, meeting predefined criteria. Data collected included age, sex, primary tumor site, disease stage, Breslow thickness, Clark level, mitotic figures, ulceration, lymphovascular invasion, sentinel lymph node involvement, and adequacy of excision margins. Statistical analysis was conducted using SPSS 26.0. Results: Significant predictors of recurrence included age \u226565 years, Breslow thickness &gt;4.0 mm, Clark level IV\u2013V, ulceration, lymphovascular invasion (P&lt;0.001), and positive sentinel lymph node biopsy (P=0.004). Inadequate excision margins were also linked to increased recurrence. Conversely, early-stage disease, thin Breslow lesions (\u22641.0 mm), and Clark level II were associated with lower recurrence risk. Conclusions: This study demonstrates a significant association between narrow excision margins and melanoma recurrence, particularly in anatomically complex areas like the head and neck. The findings underscore the importance of individualized surgical planning to ensure oncological safety while preserving function and appearance. Adherence to excision margin guidelines and long-term follow-up are essential, especially in patients with high-risk histological features.<\/jats:p>","DOI":"10.5826\/dpc.1504a6006","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:43:12Z","timestamp":1761324192000},"page":"6006","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological factors Predicting \u00a0Melanoma Recurrence: A Study from South East Ireland"],"prefix":"10.5826","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4107-4801","authenticated-orcid":false,"given":"Aneela","family":"Razzaq","sequence":"first","affiliation":[{"name":"Department of Breast, Endocrine and General Surgery, University Hospital Waterford, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Shahad","sequence":"first","affiliation":[{"name":"Watim Medical College and General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anam","family":"Allah Ditta","sequence":"first","affiliation":[{"name":"Military Hospital, Rawalpindi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27750","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"10.5826\/dpc.1504a6006_ref1","doi-asserted-by":"crossref","unstructured":"Ahme B, Qadir MI, Ghafoor S. Malignant Melanoma: Skin Cancer-Diagnosis, Prevention, and Treatment. Crit Rev Eukaryot Gene Expr. 2020;30(4):291-297. DOI: 10.1615\/CritRevEukaryotGeneExpr.2020028454. PMID: 32894659","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020028454"},{"key":"10.5826\/dpc.1504a6006_ref2","doi-asserted-by":"crossref","unstructured":"Arnold M, Singh D, Laversanne M, et al. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatol. 2022 May 1;158(5):495-503. DOI: 10.1001\/jamadermatol.2022.0160. PMID: 35546288","DOI":"10.1001\/jamadermatol.2022.0160"},{"key":"10.5826\/dpc.1504a6006_ref3","doi-asserted-by":"crossref","unstructured":"Porter E, Timoney I, Byrne B, et al. Metastatic melanoma in the Mid-West of Ireland: a retrospective review. Ir J Med Sci. 2022 Jan 8:1\u20135. DOI: 10.1007\/s11845-021-02912-9. PMID: 35546288","DOI":"10.1007\/s11845-021-02912-9"},{"key":"10.5826\/dpc.1504a6006_ref4","doi-asserted-by":"crossref","unstructured":"Leiter U, Keim U, Garbe C. Epidemiology of Skin Cancer: Update 2019. Adv Exp Med Biol. 2020;1268:123-139. DOI: 10.1007\/978-3-030-46227-7_6. PMID: 32918216","DOI":"10.1007\/978-3-030-46227-7_6"},{"key":"10.5826\/dpc.1504a6006_ref5","doi-asserted-by":"crossref","unstructured":"Choquet H, Ashrafzadeh S, Kim Y, Asgari MM, Jorgenson E. Genetic and environmental factors underlying keratinocyte carcinoma risk. JCI Insight. 2020 May 21;5(10):e134783. DOI: 10.1172\/jci.insight.134783. PMID: 32434987","DOI":"10.1172\/jci.insight.134783"},{"key":"10.5826\/dpc.1504a6006_ref6","doi-asserted-by":"crossref","unstructured":"Mar VJ, Soyer HP, Button-Sloan A, et al. Diagnosis and management of cutaneous melanoma. Aust J Gen Pract. 2020 Nov;49(11):733-739. DOI: 10.31128\/AJGP-02-20-5238. PMID: 33123704","DOI":"10.31128\/AJGP-02-20-5238"},{"key":"10.5826\/dpc.1504a6006_ref7","doi-asserted-by":"crossref","unstructured":"Bobos M. Histopathologic classification and prognostic factors of melanoma: a 2021 update. Ital J Dermatol Venerol. 2021 Jun;156(3):300-321. DOI: 10.23736\/S2784-8671.21.06958-3. PMID: 33982546","DOI":"10.23736\/S2784-8671.21.06958-3"},{"key":"10.5826\/dpc.1504a6006_ref8","unstructured":"Heistein JB, Acharya U. Malignant Melanoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. PMID: 29262210"},{"key":"10.5826\/dpc.1504a6006_ref9","unstructured":"Pathak S, Zito PM. Clinical Guidelines For The Staging, Diagnosis, and Management Of Cutaneous Malignant Melanoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan\u2013. PMID: 29262210"},{"key":"10.5826\/dpc.1504a6006_ref10","doi-asserted-by":"crossref","unstructured":"Jenkins RW, Fisher DE. Treatment of Advanced Melanoma in 2020 and Beyond. J Invest Dermatol. 2021 Jan;141(1):23-31. DOI: 10.1016\/j.jid.2020.03.943. PMID: 32386834","DOI":"10.1016\/j.jid.2020.03.943"},{"key":"10.5826\/dpc.1504a6006_ref11","doi-asserted-by":"crossref","unstructured":"Fleming NH, Tian J, Vega-Saenz de Miera E, et al. Impact of age on the management of primary melanoma patients. Oncology. 2013;85(3):173-81. DOI: 10.1159\/000351499. PMID: 24052077","DOI":"10.1159\/000351499"},{"key":"10.5826\/dpc.1504a6006_ref12","doi-asserted-by":"crossref","unstructured":"von Schuckmann LA, Hughes MCB, Ghiasvand R, et al. Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor. JAMA Dermatol. 2019 Jun 1;155(6):688-693. DOI: 10.1001\/jamadermatol.2019.0440. PMID: 31021094","DOI":"10.1001\/jamadermatol.2019.0440"},{"key":"10.5826\/dpc.1504a6006_ref13","doi-asserted-by":"crossref","unstructured":"Lyth J, Falk M, Maroti M, Eriksson H, Ingvar C. Prognostic risk factors of first recurrence in patients with primary stages I-II cutaneous malignant melanoma - from the population-based Swedish melanoma register. J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1468-1474. DOI: 10.1111\/jdv.14280. PMID: 28515668","DOI":"10.1111\/jdv.14280"},{"key":"10.5826\/dpc.1504a6006_ref14","doi-asserted-by":"crossref","unstructured":"Feigelson HS, Powers JD, Kumar M, Carroll NM, Pathy A, Ritzwoller DP. Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study. Cancer Med. 2019 Aug;8(9):4508-4516. DOI: 10.1002\/cam4.2252. PMID: 31366147","DOI":"10.1002\/cam4.2252"},{"key":"10.5826\/dpc.1504a6006_ref15","doi-asserted-by":"crossref","unstructured":"Liang C, Hu W, Li J, Zhang X, Zhou Z, Liang Y. Early time to recurrence predicts worse survival in patients with localized or regionally advanced cutaneous melanoma. Dermatol Ther. 2021 Jul;34(4):e14981. DOI: 10.1111\/dth.14981. PMID: 34052802","DOI":"10.1111\/dth.14981"},{"key":"10.5826\/dpc.1504a6006_ref16","doi-asserted-by":"crossref","unstructured":"Oh Y, Choi S, Cho MY, et al. Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations. J Am Acad Dermatol. 2020 Oct;83(4):1071-1079. DOI: 10.1016\/j.jaad.2019.09.029. PMID: 31521913","DOI":"10.1016\/j.jaad.2019.09.029"},{"key":"10.5826\/dpc.1504a6006_ref17","doi-asserted-by":"crossref","unstructured":"Reschke R, Dumann K, Ziemer M. Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years). J Clin Med. 2022 Apr 5;11(7):2026. DOI: 10.3390\/jcm11072026. PMID: 35408499","DOI":"10.3390\/jcm11072026"},{"key":"10.5826\/dpc.1504a6006_ref18","doi-asserted-by":"crossref","unstructured":"Tas F, Erturk K. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors. Melanoma Res. 2017 Apr;27(2):134-139. DOI: 10.1097\/CMR.0000000000000332. PMID: 28114588","DOI":"10.1097\/CMR.0000000000000332"},{"key":"10.5826\/dpc.1504a6006_ref19","doi-asserted-by":"crossref","unstructured":"Kim D, Chu S, Khan AU, et al. Risk factors and patterns of recurrence after sentinel lymph node biopsy for thin melanoma. Arch Dermatol Res. 2022 Apr;314(3):285-292. DOI: 10.1007\/s00403-021-02229-8. PMID: 34905293","DOI":"10.1007\/s00403-021-02229-8"},{"key":"10.5826\/dpc.1504a6006_ref20","doi-asserted-by":"crossref","unstructured":"Tas F, Erturk K. Different mitotic rates are associated with different prognostic factors, relapses, and survival rates in melanoma. Int J Dermatol. 2022 Apr;61(4):472-479. DOI: 10.1111\/ijd.15939. PMID: 34905293","DOI":"10.1111\/ijd.15939"}],"container-title":["Dermatology Practical &amp; Conceptual"],"original-title":[],"link":[{"URL":"https:\/\/www.dpcj.org\/index.php\/dpc\/article\/download\/6006\/3218","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dpcj.org\/index.php\/dpc\/article\/download\/6006\/3657","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dpcj.org\/index.php\/dpc\/article\/download\/6006\/3218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T09:34:34Z","timestamp":1765532074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dpcj.org\/index.php\/dpc\/article\/view\/6006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5826\/dpc.1504a6006","relation":{"has-manifestation":[{"id-type":"other","id":"1-81-6006-g3218","asserted-by":"subject"},{"id-type":"other","id":"1-81-6006-g3657","asserted-by":"subject"}],"is-part-of":[{"id-type":"doi","id":"10.5826\/dpc.1504a%a","asserted-by":"subject"}]},"ISSN":["2160-9381"],"issn-type":[{"type":"electronic","value":"2160-9381"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"8"}}